Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 1.40% is 354% above its 5-year average of -0.55%, around the middle of its 5-year range (-5.99%–6.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 355.61% above its 12-month average of 0.31%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 1.40%.
RETURN ON EQUITY (ROE)
1.40%
RETURN ON EQUITY (ROE) AVG TTM
0.31%
RETURN ON EQUITY (ROE) AVG 3Y
-2.00%
RETURN ON EQUITY (ROE) AVG 5Y
-0.55%
RETURN ON EQUITY (ROE) AVG 10Y
2.57%
RETURN ON EQUITY (ROE) AVG 15Y
4.83%
RETURN ON EQUITY (ROE) AVG 20Y
6.22%
CURRENT VS TTM AVG
+355.61%
CURRENT VS 3Y AVG
+170.04%
CURRENT VS 5Y AVG
+353.58%
CURRENT VS 10Y AVG
-45.50%
CURRENT VS 15Y AVG
-71.06%
CURRENT VS 20Y AVG
-77.53%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+103.33%
vs the sector median at left
ICU Medical, Inc.
Market Cap
$3.96B
Return on Equity (ROE)
1.40%
TTM Avg
0.31%
3Y Avg
-2.00%
5Y Avg
-0.55%
Market Cap
$4.03B
Return on Equity (ROE)
-18.38%
TTM Avg
-15.28%
3Y Avg
-7.60%
5Y Avg
-0.19%
Market Cap
$4.03B
Return on Equity (ROE)
-32.14%
TTM Avg
-46.09%
3Y Avg
-42.05%
5Y Avg
-35.94%
Market Cap
$3.85B
Return on Equity (ROE)
-73.75%
TTM Avg
-63.05%
3Y Avg
-54.60%
5Y Avg
-25.68%
Market Cap
$4.13B
Return on Equity (ROE)
14.23%
TTM Avg
-7.71%
3Y Avg
-5.30%
5Y Avg
-10.52%
Market Cap
$4.33B
Return on Equity (ROE)
-44.02%
TTM Avg
-30.64%
3Y Avg
-28.05%
5Y Avg
-12.80%
Market Cap
$3.56B
Return on Equity (ROE)
-7.50%
TTM Avg
-76.90%
3Y Avg
-65.24%
5Y Avg
-51.68%
Market Cap
$3.56B
Return on Equity (ROE)
8.25%
TTM Avg
3.56%
3Y Avg
-0.85%
5Y Avg
-3.10%
Market Cap
$4.39B
Return on Equity (ROE)
-44.68%
TTM Avg
-52.94%
3Y Avg
-55.51%
5Y Avg
-46.01%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICU Medical, Inc. (ICUI) | $3.96B | 1.40% | 0.31% | -2.00% | -0.55% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.03B | -18.38% | -15.28% | -7.60% | -0.19% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.03B | -32.14% | -46.09% | -42.05% | -35.94% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.85B | -73.75% | -63.05% | -54.60% | -25.68% |
| LivaNova PLC (LIVN)vs › | $4.13B | 14.23% | -7.71% | -5.30% | -10.52% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.33B | -44.02% | -30.64% | -28.05% | -12.80% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | -7.50% | -76.90% | -65.24% | -51.68% |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 8.25% | 3.56% | -0.85% | -3.10% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | -44.68% | -52.94% | -55.51% | -46.01% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.52B | -32.94% | -45.25% | -31.88% | -26.45% |
ROE
1.4%
ROA
0.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 1.40% |
| 2026-03-31 | 2.19% |
| 2025-12-31 | 0.03% |
| 2025-09-30 | -0.35% |
| 2025-06-30 | -1.75% |
| 2025-03-31 | -4.71% |
| 2024-12-31 | -5.99% |
| 2024-09-30 | -5.42% |
| 2024-06-30 | -3.47% |
| 2024-03-31 | -2.87% |
| 2023-12-31 | -1.40% |
| 2023-09-30 | -1.34% |
| 2023-06-30 | -2.29% |
| 2023-03-31 | -2.19% |
| 2022-12-31 | -3.55% |
| 2022-09-30 | -1.93% |
| 2022-06-30 | 0.26% |
| 2022-03-31 | 1.90% |
| 2021-12-31 | 6.38% |
| 2021-09-30 | 6.88% |
| 2021-06-30 | 6.63% |
| 2021-03-31 | 6.17% |
| 2020-12-31 | 5.78% |
| 2020-09-30 | 5.60% |
| 2020-06-30 | 5.88% |
| 2020-03-31 | 6.31% |
| 2019-12-31 | 7.34% |
| 2019-09-30 | 5.45% |
| 2019-06-30 | 3.54% |
| 2019-03-31 | 4.28% |
| 2018-12-31 | 2.28% |
| 2018-09-30 | 6.81% |
| 2018-06-30 | 6.82% |
| 2018-03-31 | 1.44% |
| 2017-12-31 | 5.73% |
| 2017-09-30 | 2.49% |
| 2017-06-30 | 4.20% |
| 2017-03-31 | 8.83% |
| 2016-12-31 | 9.56% |
| 2016-09-30 | 9.10% |
| 2016-06-30 | 9.17% |
| 2016-03-31 | 8.97% |
| 2015-12-31 | 7.76% |
| 2015-09-30 | 8.27% |
| 2015-06-30 | 6.89% |
| 2015-03-31 | 5.67% |
| 2014-12-31 | 5.18% |
| 2014-09-30 | 6.57% |
| 2014-06-30 | 7.60% |
| 2014-03-31 | 8.10% |
| 2013-12-31 | 8.70% |
| 2013-09-30 | 9.12% |
| 2013-06-30 | 9.79% |
| 2013-03-31 | 10.50% |
| 2012-12-31 | 10.56% |
| 2012-09-30 | 12.54% |
| 2012-06-30 | 12.48% |
| 2012-03-31 | 13.00% |
| 2011-12-31 | 13.93% |
| 2011-09-30 | 11.99% |
| 2011-06-30 | 11.89% |
| 2011-03-31 | 12.01% |
| 2010-12-31 | 11.28% |
| 2010-09-30 | 10.82% |
| 2010-06-30 | 10.50% |
| 2010-03-31 | 9.68% |
| 2009-12-31 | 10.02% |
| 2009-09-30 | 10.15% |
| 2009-06-30 | 10.96% |
| 2009-03-31 | 10.90% |
| 2008-12-31 | 9.60% |
| 2008-09-30 | 8.89% |
| 2008-06-30 | 7.95% |
| 2008-03-31 | 7.36% |
| 2007-12-31 | 10.79% |
| 2007-09-30 | 10.82% |
| 2007-06-30 | 10.97% |
| 2007-03-31 | 12.76% |
| 2006-12-31 | 11.41% |
| 2006-09-30 | 11.06% |
| 2006-06-30 | 11.30% |
| 2006-03-31 | 11.14% |
| 2005-12-31 | 10.72% |
| 2005-09-30 | 7.59% |
| 2005-06-30 | 3.86% |
| 2005-03-31 | 3.23% |
| 2004-12-31 | 3.20% |
| 2004-09-30 | 8.68% |
| 2004-06-30 | 11.22% |
| 2004-03-31 | 12.05% |
| 2003-12-31 | 14.29% |
| 2003-09-30 | 14.33% |
| 2003-06-30 | 14.38% |